Credit: Pixelvario/Shutterstock.com
The recent passage of the Inflation Reduction Act of 2022 (IRA) has significant health insurance implications for Americans, with $98 billion of its $485 billion in spending going to health care programs. This spending is mostly in the area of expanding government subsidies for those on Affordable Care Act (ACA) individual plans — but the plan also saves money by redesigning Medicare pharmacy spending to include negotiating prices for some drugs. An analysis by the Kaiser Family Foundation estimated that the drug pricing provisions would save the government close to $100 billion over ten years.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
